Online citations, reference lists, and bibliographies.
← Back to Search

Resistance To Insulin Therapy Among Patients And Providers: Results Of The Cross-national Diabetes Attitudes, Wishes, And Needs (DAWN) Study.

M. Peyrot, R. Rubin, T. Lauritzen, S. Skovlund, F. Snoek, D. Matthews, R. Landgraf, L. Kleinebreil
Published 2005 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
OBJECTIVE To examine the correlates of patient and provider attitudes toward insulin therapy. RESEARCH DESIGN AND METHODS Data are from surveys of patients with type 2 diabetes not taking insulin (n = 2,061) and diabetes care providers (nurses = 1,109; physicians = 2,681) in 13 countries in Asia, Australia, Europe, and North America. Multiple regression analysis is used to identify correlates of attitudes toward insulin therapy among patients, physicians, and nurses. RESULTS Patient and provider attitudes differ significantly across countries, controlling for individual characteristics. Patients rate the clinical efficacy of insulin as low and would blame themselves if they had to start insulin therapy. Self-blame is significantly lower among those who have better diet and exercise adherence and less diabetes-related distress. Patients who are not managing their diabetes well (poor perceived control, more complications, and diabetes-related distress) are significantly more likely to see insulin therapy as potentially beneficial. Most nurses and general practitioners (50-55%) delay insulin therapy until absolutely necessary, but specialists and opinion leaders are less likely to do so. Delay of insulin therapy is significantly less likely when physicians and nurses see their patients as more adherent to medication or appointment regimens, view insulin as more efficacious, and when they are less likely to delay oral diabetes medications. CONCLUSIONS Patient and provider resistance to insulin therapy is substantial, and for providers it is part of a larger pattern of reluctance to prescribe blood glucose-lowering medication. Interventions to facilitate timely initiation of insulin therapy will need to address factors associated with this resistance.
This paper references
Insulin-Therapy Resistance
G. Koerbel (2003)
Psychological insulin resistance: a challenge for diabetes patients and health care professionals
CA Leslie (1995)
10.2337/DIACARE.23.6.765
Diabetes Fear of Injecting and Self-Testing Questionnaire: a psychometric evaluation.
E. Mollema (2000)
10.1177/0145721706289226
Psychological insulin resistance: overcoming barriers to starting insulin therapy.
S. Davis (2006)
Factors linked JAMA 274:700–705, 1995 to the prescribing of benzodiazepines
MA Cormack (1992)
10.1016/S0140-6736(98)07019-6
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
UK Prospective Diabetes Study Group (1998)
10.1093/FAMPRA/8.4.314
A study of the relationship between patients' attitudes and doctors' prescribing.
A. Virji (1991)
10.3109/10401239609147752
The use of antidepressants and therapeutic drug monitoring by general practitioners and psychiatrists: findings from a questionnaire survey in two Swedish areas.
G. Isacsson (1996)
An international study of psychological resistance to insulin use among persons with diabetes (Abstract)
M Peyrot (2005)
Outpatient insulin 0.005 0.243§ 0.052 therapy in type 1 and type 2 diabetes
DE De Witt (2003)
Patient-provider relationship: a therapeutic tool in overcoming psychological insulin resistance (Abstract)
Boga ˘tean Pop Mirela (2004)
10.2337/DIACARE.28.11.2673
Resistance to Insulin Therapy Among Patients and Providers Results of the cross-national Diabetes Attitudes, Wishes, and Needs (DAWN) study
M. Peyrot (2005)
10.2337/DIACARE.27.7.1535
The burden of treatment failure in type 2 diabetes.
J. Brown (2004)
10.1177/1077558703060002003
Differential Adoption of Pharmacotherapy Recommendations for Type 2 Diabetes by Generalists and Specialists
M. Pugh (2003)
Early insulin therapy for 0.138 0.092 type 2 diabetes
MB Davidson (2005)
10.1001/JAMA.1995.03530090032018
Changing physician performance. A systematic review of the effect of continuing medical education strategies.
D. Davis (1995)
10.1002/PDI.670
People with type 2 diabetes facing the reality of starting insulin therapy: factors involved in psychological insulin resistance
M. Bogatean (2004)
Is - sues relating to the early or earlier use of insulin in type 2 diabetes
JB Brown (2003)
Diabetes fear of injecting and selftesting questionnaire
ED Mollema (2000)
10.1177/014572170403000220
Self-Management Support for Insulin Therapy in Type 2 Diabetes
M. Funnell (2004)
Psychological insulin resistance: a missed diagnosis
CA Leslie (1994)
Barriers and facilitators in relation to starting insulin therapy in type 2
K Okazaki
10.1097/00002508-199712000-00011
What factors affect physicians' decisions to prescribe opioids for chronic noncancer pain patients?
D. Turk (1997)
10.2337/DIACARE.28.1.220
Early insulin: an important therapeutic strategy.
G. Dailey (2005)
Van Der Ploeg HM: Diabetes fear of injecting and self-testing questionnaire
Ed Mollema (2000)
10.1111/j.1464-5491.2005.01644.x
Psychosocial problems and barriers to improved diabetes management: results of the Cross‐National Diabetes Attitudes, Wishes and Needs (DAWN) Study
M. Peyrot (2005)
10.2337/DIACARE.28.2.427
Availability of inhaled insulin promotes greater perceived acceptance of insulin therapy in patients with type 2 diabetes.
N. Freemantle (2005)
Physicians’ knowledge of drug costs for S: An international study of psychological the elderly. J Am Geriatrics Soc 42:992– resistance to insulin use among persons
L Glickman (1994)
10.1038/sj.ijo.0802173
When oral agents fail: practical barriers to starting insulin
M. Korytkowski (2002)
10.2337/diacare.20.3.292
NIDDM Patients' Fears and Hopes About Insulin Therapy: The basis of patient reluctance
L. Hunt (1997)
The DAWN (Diabetes AttiRedfors I, Sjoqvist F: The use of antitudes, Wishes and Needs) study. Practical depressants and therapeutic drug
G Isacsson (2002)
10.1093/FAMPRA/9.4.466
Factors linked to the prescribing of benzodiazepines by general practice principals and trainees.
M. Cormack (1992)
10.1016/0277-9536(95)00387-8
Factors influencing physicians' prescribing behaviour in the treatment of childhood diarrhoea: knowledge may not be the clue.
P. Paredes (1996)
HM: Diabetes fear of injecting and self-testing questionnaire
ED Mollema (2000)
The bur0.040 0.008 0.004 den of treatment failure in type 2 diabetes
JB Brown (2004)
Early insulin: an important NS 0.076‡ 0.063 therapeutic strategy. Diabetes Care
GE Dailey (2005)
Insulin therapy and the reluctant patient. Overcoming obstacles to success.
E. C. Bashoff (1995)
10.1001/JAMA.289.17.2254
Outpatient insulin therapy in type 1 and type 2 diabetes mellitus: scientific review.
D. Dewitt (2003)
10.1002/pdi.305
The DAWN (Diabetes Attitudes, Wishes and Needs) study
G. Alberti (2002)
Factors linked JAMA 274:700–705
MA Cormack (1995)
10.2337/DIACLIN.22.3.147
What's So Tough About Taking Insulin? Addressing the Problem of Psychological Insulin Resistance in Type 2 Diabetes
W. Polonsky (2004)
Barriers and Facilitators in Relation to Starting Insulin Therapy in Type 2 Diabetes
K. Okazaki (1999)
Patient-provider relationship: a therapeutic tool in overcoming psychological insulin resistance (Abstract)
Mirela Bogătean Pop (2004)
10.1111/j.1532-5415.1994.tb06594.x
Physicians' Knowledge of Drug Costs for the Elderly
L. Glickman (1994)
10.1002/JCLP.1041
Psychological issues and treatments for people with diabetes.
R. Rubin (2001)
10.1016/0277-9536(82)90268-4
Factors related to the prescribing of selected psychotropic drugs by primary care physicians.
R. Hadsall (1982)
10.2337/diacare.21.9.1391
Attitudes of Primary Care Providers Toward Diabetes: Barriers to guideline implementation
A. Larme (1998)
10.1080/10401339009539424
House officer attitudes, beliefs, and recording behavior associated with prescribing minor tranquilizers
David G. Buchsbaum (1987)
Improving performance in diabetes care: a multicomponent intervention.
M. Nyman (2000)
A study of the relationponent intervention
A Virji (2000)
10.2337/DIACARE.29.04.06.DC05-2428
Resistance to insulin therapy among patients and providers: results of the cross-national diabetes attitudes, wishes, and needs (DAWN) study.
G. Phillipov (2006)
10.1016/0738-3991(93)90091-A
Determinants of injecting insulin in elderly patients with type II diabetes mellitus.
B. Wolffenbuttel (1993)
macotherapy recommendations for type 2 Factors related to the prescribing of sediabetes by generalists and specialists. lected psychotropic drugs by primary
RS Hadsall (2003)
10.1002/PDI.433
Issues relating to the early or earlier use of insulin in type 2 diabetes
P. Home (2003)
Helper CD: Drug choice as a Diaz J, Trostle J: Factors influencing phyproblem-solving process
R Segal (1985)
10.1177/030802265201500209
Abstract
Mustafa (1952)
10.1002/1097-0142(19951201)76:11<2375::AID-CNCR2820761129>3.0.CO;2-C
Oncologists and primary care physicians' attitudes toward pain control and morphine prescribing in france
F. Larue (1995)
10.1097/00005650-198508000-00004
Drug Choice as a Problem-solving Process
R. Segal (1985)
Barriers to insulin therapy in type 2 diabetes: a qualitative focus group research among patients, GPs and diabetologists
T Lauritzen (2001)
Appraisal of insulin therapy among type 2 diabetes patients with and without previous experience of insulin therapy (Abstract)
SE Skovlund (2005)
10.1016/S0168-8227(99)00099-6
Injection related anxiety in insulin-treated diabetes.
A. Zambanini (1999)
Attitudes of primary may not be the clue. Soc Sci Med 42:1141– care providers toward diabetes: barriers to 1153, 1996 guideline implementation. Diabetes Care
AC Larme (1998)
An international study of psychological resistance to insulin use among persons with diabetes ( Abstract )
R Colagiuri (2003)



This paper is referenced by
10.1186/1472-6823-9-19
The consequences of delaying insulin initiation in UK type 2 diabetes patients failing oral hyperglycaemic agents: a modelling study
G. Goodall (2009)
Comparing and contrasting healthcare professionals' and patients' perceptions, understanding and experiences of Type 2 Diabetes (T2D) and its management : a qualitative study
Paul Newton (2014)
Clinical Use of Incretin-Based Therapy in Type 2 Diabetes Mellitus
M. Shomali (2011)
10.7243/2050-0866-8-1
Treatment persistence behaviours in patients with type 2 diabetes (T2DM) after initiation of basal insulin: An exploratory analysis from a Spanish real-world sample
Miriam Rubio de Santos (2019)
10.2196/jmir.6944
InsuOnline, an Electronic Game for Medical Education on Insulin Therapy: A Randomized Controlled Trial With Primary Care Physicians
L. Diehl (2017)
10.1097/SMJ.0b013e31802ed2ea
Why and How to Use Insulin Therapy Earlier in the Management of Type 2 Diabetes
L. Meneghini (2007)
10.1016/j.diabet.2009.06.004
Insulin detemir improves glycaemic control with less hypoglycaemia and no weight gain: 52-week data from the PREDICTIVE study in a cohort of French patients with type 1 or type 2 diabetes.
M. Marre (2009)
Addressing Barriers to Timely Intensification of Diabetes Care: The Relationship Between Clinical Inertia and Patient Behavior
D. Kruger (2009)
10.1111/j.1742-1241.2009.02176.x
Barriers to insulin initiation and intensification and how to overcome them
T. Kunt (2009)
10.1111/j.1463-1326.2008.00980.x
Insulin glargine provides greater improvements in glycaemic control vs. intensifying lifestyle management for people with type 2 diabetes treated with OADs and 7–8% A1c levels. The TULIP study
J. Blicklé (2009)
Tilburg University Development and validation of the insulin treatment appraisal scale ( ITAS ) in patients with type 2 diabetes
F. Snoek (2008)
10.2337/dc10-0494
Initiating Insulin as Part of the Treating To Target in Type 2 Diabetes (4-T) Trial
N. Jenkins (2010)
10.1007/s12325-019-00907-8
Appropriate Titration of Basal Insulin in Type 2 Diabetes and the Potential Role of the Pharmacist
D. Patel (2019)
10.1007/s00592-014-0572-4
Duration of diabetes and effectiveness of insulin in the management of insulin-naïve Korean patients uncontrolled on oral antidiabetic drugs: a sub-analysis of the MOdaliTy of Insulin treatment eValuation (MOTIV) registry results
S. Kim (2014)
10.1186/1748-5908-9-20
Can primary care team-based transition to insulin improve outcomes in adults with type 2 diabetes: the stepping up to insulin cluster randomized controlled trial protocol
J. Furler (2014)
10.1186/1472-6823-12-20
Rationale and design of the multinational observational study assessing insulin use: the MOSAIc study
J. Polinski (2012)
Rejection of insulin therapy among patients with type 2 diabetes in China: reasons and recommendations.
Zhenzhen Xiong (2014)
10.3122/jabfm.2019.03.180162
Initiation and Titration of Basal Insulin in Primary Care: Barriers and Practical Solutions
L. Perreault (2019)
WHO EMRO | Barriers to initiation of insulin therapy in poorly controlled type 2 diabetes based on self-determination theory
Armin Rajab (2020)
10.1185/03007990903421994
Persistence with injectable antidiabetic agents in members with type 2 diabetes in a commercial managed care organization
C. Cooke (2010)
10.2337/dc08-0315
Efficacy and Safety of Technosphere Inhaled Insulin Compared With Technosphere Powder Placebo in Insulin-Naive Type 2 Diabetes Suboptimally Controlled With Oral Agents
J. Rosenstock (2008)
10.1111/j.1463-1326.2012.01613.x
Factors influencing initial choice of insulin therapy in a large international non-interventional study of people with type 2 diabetes
N. Freemantle (2012)
10.12669/pjms.35.1.237
Barriers to the early initiation of Insulin therapy among diabetic patients coming to diabetic clinics of tertiary care hospitals
Iqra Arshad (2019)
10.1111/dom.12136
Options for prandial glucose management in type 2 diabetes patients using basal insulin: addition of a short‐acting GLP‐1 analogue versus progression to basal‐bolus therapy
I. Hirsch (2014)
10.1111/dom.12214
More satisfied, but why? A pooled patient‐level analysis of treatment satisfaction following the initiation of insulin glargine vs. comparators in insulin‐naïve patients with type 2 diabetes mellitus
W. Polonsky (2014)
10.1371/journal.pone.0163350
Efficacy and Safety of Once-Daily Insulin Degludec/Insulin Aspart versus Insulin Glargine (U100) for 52 Weeks in Insulin-Naïve Patients with Type 2 Diabetes: A Randomized Controlled Trial
A. Kumar (2016)
10.1177/193229681300700514
Using Simulation Technology to Teach Diabetes Care Management Skills to Resident Physicians
J. Sperl-Hillen (2013)
10.2337/diaspect.22.4.248
A Qualitative Assessment of Educational Opportunities for Primary Care Providers in Type 2 Diabetes Care
K. Cytryn (2009)
10.5603/EP.a2018.0037
Dose titration model and correlative factors analysis in Chinese patients with type-2 diabetes on basal insulin - results from an Observational Registry of Basal Insulin Treatment study.
J. Chen (2018)
10.2298/VSP101216018S
[Different insulin treatment regimens in patient with diabetes mellitus type 1: effects on quality of life].
J. Stojanovic (2012)
10.5580/d20
Biphasic Insulin Analogs for Treatment of Diabetes: A Review
J. Tibaldi (2009)
10.1089/dia.2008.0131
Exubera inhaled insulin in patients with type 1 and type 2 diabetes: the first 12 months.
Victoria Alabraba (2009)
See more
Semantic Scholar Logo Some data provided by SemanticScholar